Gilead Sciences said Monday that it was paying $11.9 billion to acquire Kite Pharma, a firm which could soon have the first cell therapies available to sufferers of certain types of cancers.
"The acquisition of Kite establishes Gilead as a leader in cellular therapy and provides a foundation from which to drive continued innovation for people with advanced cancers,” Gilead's chief executive John Milligan said in a statement.
Cell therapy is an emerging field which uses a patient’s own immune cells to fight cancer.
Kite could have the first cell therapy available on the market for certain types of non-Hodgkin lymphoma, with the US Food and Drug Administration set to render a decision in November, the statement said.
The European Medicines Agency is expected to issue its decision next year.
"We are greatly impressed with the Kite team and what they have accomplished, and share their belief that cell therapy will be the cornerstone of treating cancer," said Milligan.
The $180 per share in cash that Kite shareholders will receive is a 29 percent premium over its closing price on Friday.
The transaction is expected to close by the end of the year, the companies said.
Gilead said the acquisition of Kite will help it diversify revenues, and would help increase earnings after three years.
Gilead recently increased its earnings forecast for this year after a better-than-expected second quarter, but it has had to face slowing sales of its leading hepatitis C treatments.
New rival drugs that cost a fraction of Gilead's treatments and are similarly effective have recently hit the market.
source: AFP
GMT 17:13 2017 Tuesday ,19 December
GPIC outstanding staff honouredGMT 05:42 2017 Monday ,18 December
French aerospace giant Thales acquires SIM maker GemaltoGMT 11:23 2017 Saturday ,16 December
Euro zone businesses to start 2018 on near seven-year highGMT 12:19 2017 Thursday ,14 December
Zara owner Inditex profits up on strong salesGMT 16:40 2017 Tuesday ,12 December
BAS employs 95% Bahraini staffGMT 13:36 2017 Tuesday ,12 December
Airbus to pay compensation to 2007 Brazil crash victimsGMT 09:23 2017 Monday ,11 December
Two Lafarge bosses charged over jihadist fundingGMT 06:09 2017 Saturday ,09 December
Germany's BASF agrees oil merger with Russian tycoon's firmMaintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2023 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2023 ©